Go to deals
Private Equity | Healthcare

Anbioton has been acquired by Elfa Medicamentos

The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.

Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.

Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.

One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.

Service
M&A sell-side
Parties

Talk to the deal team

 Irajá  Guimarães

Irajá Guimarães

Partner
São Paulo, Brazil
Oaklins Olimpia Partners
 Victor  Andreoli

Victor Andreoli

Partner
São Paulo, Brazil
Oaklins Olimpia Partners
 Thomas  Monteiro

Thomas Monteiro

Partner
São Paulo, Brazil
Oaklins Olimpia Partners

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Confirma Software has acquired Quick Systems
Private Equity | TMT

Confirma Software has acquired Quick Systems

Quick Systems AS has become part of Confirma Software, backed by Abry Partners.

Learn more
Agar Scientific has been acquired by Calibre Scientific
Private Equity | Healthcare

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Learn more